Lung Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type (Small Cell Lung Cancer, Non-Small Cell Lung Cancer), By Test (CA Tests, HER2 Tests, ALK Tests), By End Use, Region And Segment Forecasts, 2024 - 2030

Market Segmentation

• Lung Cancer Diagnostics Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Non-small cell lung cancer
  • Small cell lung cancer  
• Lung Cancer Diagnostics Test Outlook (Revenue, USD Billion, 2018 - 2030)
  • CA test
  • HER2 test
  • ALK test
  • Angiogenesis Inhibitors
  • EGFR Mutation test
  • KRAS Mutation test
• Lung Cancer Diagnostics End Use Outlook (Revenue, USD Billion, 2018 - 2030)
  • Hospitals and clinics
  • Diagnostic Laboratories
  • Others
• Lung Cancer Diagnostics Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • Kuwait
    • South Africa

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance